Advertisement

Angiotech Pharmaceuticals Inc. says the Supreme Court of British Columbia has issued a sanction order approving the Vancouver medical devices company's second amended restructuring plan under the Companies' Creditors Arrangement Act (Canada).

Advertisement
Advertisement